Clinical investigation of medicinal products for prevention of venous thromboembolism (VTE) in patients undergoing high VTE-risk surgery

Current effective version

PDF iconRevision 2 - Adopted guideline

Reference numberEMA/CHMP/325170/2012 Rev.2
Published30/05/2013
Effective from30/11/2013
KeywordsCHMP, venous thromboembolic risk
DescriptionThis document provides guidance for the evaluation of new medicinal products in the primary prophylaxis of high intra- and post-operative venous thrombo-embolic risk.


Document history

Revision 2

Current version

PDF iconAdopted guideline

PDF iconOverview of comments

PDF iconDraft guideline

PDF iconConcept paper

In operation: 30/11/2013–present

Published: 30/05/2013

Published: 30/05/2012

Published: 01/07/2011

Revision 1

PDF iconAdopted guideline

PDF iconOverview of comments

PDF iconDraft guideline

PDF iconConcept paper

In operation: 31/05/2008–29/11/2013

Published: 15/11/2007

Published: 16/11/2006

Published: 17/11/2005

First version PDF iconPoints to consider Published: 29/06/2000


Related content


How useful was this page?

Add your rating